1 unknown. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Unknown 1 |
Follow Interleukin-21: new trials by email Literature Review of Interleukin-21 trials Research Report on Interleukin-21
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 1 First-in-human Study of JS014 JS014, Interleukin 21 and humanized anti-human serum albumin VHH antibody, Pembrolizumab - anti-PD-1 antibody - Neoplasm Malignant, Neoplasm, Experimental | Phase 1 | Unknown | Anwita Biosciences | 60 | 2022-02-28 | 2023-09-06 |
Lymphoma (1) · Neoplasms (1) · Neoplasms, Experimental (1)
Taiwan (1)
TJ Chiou, MD (1)